logo
logo

Eysz Announces Investment In Its Epilepsy Management Platform By The Hundley Foundation

Jul 26, 2021•about 4 years ago
San Francisco

Description

Eysz, a startup developing a digital health platform to enable personalized medicine for neurological disorders starting with epilepsy, announced today that The Hundley Foundation, a charity established by NFL quarterback Brett Hundley and his sister Paris in 2019 to improve the lives of children and families in need, has invested in Eysz via its Regulation Crowdfunding (Reg. CF) offering. The Reg CF offering, currently listed on the Bioverge Portal, LLC (details available at https://biovergeportal.com/startups/30-eysz-inc), will allow everyone, accredited and non-accredited investors, the opportunity to invest in the further development of Eysz's Epilepsy Management Platform.

Company Information

Company

Eysz

Location

San Francisco, California, United States

About

Eysz is a startup developing a digital health platform to enable personalized medicine for neurological disorders starting with epilepsy, one of the most common and expensive neurological disorders. The goal of epilepsy treatment is to stop seizures with minimal side effects as quickly as possible. However, doctors do not have the reliable data they need to accurately measure treatment outcomes. Eysz's unique AI-based software analyzes passive eye-movements from compatible eye-tracking systems to assist clinicians in understanding their patient's seizure burden and neurocognitive side effects enabling them to create a more personalized care plan, potentially resulting in better quality of life, improved treatment adherence, and lower costs. To learn more, visit www.eyszlab.com.